What is Aspira Pathlab & Diagnostics Ltd. Quarterly Revenue?

Aspira Pathlab & Diagnostics Ltd. Quarterly Revenue Aspira Pathlab Jun-2026 Quarterly Revenue is Rs 6 Cr which is growth of 17.4% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Quarterly Net Profit?

Aspira Pathlab & Diagnostics Ltd. Quarterly Net Profit Aspira Pathlab Jun-2026 Quarterly Net Profit is Rs -0 Cr which is growth of -108.0% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Annual Revenue?

Aspira Pathlab & Diagnostics Ltd. Annual Revenue Aspira Pathlab Mar-2026 Annual Revenue is Rs 25 Cr which is growth of 13.9% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Annual Net Profit?

Aspira Pathlab & Diagnostics Ltd. Annual Net Profit Aspira Pathlab Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of -97.5% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Total Shareholders Fund?

Aspira Pathlab & Diagnostics Ltd. Total Shareholders Fund Aspira Pathlab Mar-2026 Total Shareholders Fund is Rs 9 Cr which is growth of 1.9% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Total Assets?

Aspira Pathlab & Diagnostics Ltd. Total Assets Aspira Pathlab Mar-2026 Total Assets is Rs 19 Cr which is growth of 5.7% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Book Value Per Share?

Aspira Pathlab & Diagnostics Ltd. Book Value Per Share Aspira Pathlab Mar-2026 Book Value Per Share is 7 Rs which is growth of 0.2% YoY.

What is Aspira Pathlab & Diagnostics Ltd. ROE?

Aspira Pathlab & Diagnostics Ltd. ROE Aspira Pathlab Mar-2026 ROE is 1% which is growth of 27.7% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Cash From Operating Activity?

Aspira Pathlab & Diagnostics Ltd. Cash From Operating Activity Aspira Pathlab Mar-2026 Cash From Operating Activity is Rs 1 Cr which is growth of -22.6% YoY.

What is Aspira Pathlab & Diagnostics Ltd. Net Cash Flow?

Aspira Pathlab & Diagnostics Ltd. Net Cash Flow Aspira Pathlab Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -151.4% YoY.

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788|

Download real time

0.05(0.04%)

New 52W High in past week

2,616

BSE Volume

High vol.+gain this week

BSE 25 Sep, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Aspira Pathlab quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Aspira Pathlab quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Aspira Pathlab Jun-2026 Quarterly Revenue is Rs 6 Cr which is growth of 17.4% YoY.
NEGATIVE
Quarterly Net Profit Aspira Pathlab Jun-2026 Quarterly Net Profit is Rs -0 Cr which is growth of -108.0% YoY.

Aspira Pathlab & Diagnostics Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	6.3	6.7	5.3	8.2	5.4	5.9	5.5	6.3	4.7	3.9	3.6	3.5	2.7
SR_Q Operating Rev.	6.2	6.5	5.1	8.1	5.3	5.8	5.4	6.2	4.6	3.8	3.5	3.3	2.6
OI_Q Other Income	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
OEXPNS_Q Operating Exp.	5.8	6.9	6.3	5.9	4.4	4.7	4.6	4.8	4.3	3.9	3.8	3.7	2.9
OEXPNS_Q Operating Exp.	5.8	6.9	6.3	5.9	4.4	4.7	4.6	4.8	4.3	3.9	3.8	3.7	2.9
OP_Q Operating Profit	0.3	-0.3	-1.2	2.2	0.8	1.1	0.8	1.4	0.4	-0.1	-0.4	-0.4	-0.3
OPMPCT_Q Operating Profit Margin %	5.57%	-5.11%	-23.64%	27.05%	15.64%	18.24%	14.20%	21.97%	7.53%	-3.10%	-10.75%	-11.10%	-12.56%
DEP_Q Depr.	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
INT_Q Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
PBT_Q Profit Before Tax	-0	-0.7	-1.6	1.8	0.5	0.7	0.4	1	-0	-0.5	-0.7	-0.7	-0.7
TAX_Q Tax
NP_Q Net Profit	-0	-0.7	-1.6	1.8	0.5	0.7	0.4	1	-0	-0.5	-0.7	-0.7	-0.7
EPS_adj_Q EPS Adj. latest	-0	-0.7	-1.5	1.8	0.5	0.7	0.4	1	-0	-0.5	-0.7	-0.7	-0.7
NP_TTM Net profit TTM	-0.5	0.1	1.5	3.4	2.6	2.1	0.9	-0.3	-2	-2.7	-2.4	-1.3	-0.5
EPS_TTM Basic EPS TTM	-0.4	0.1	1.4	3.3	2.5	2	0.8	-0.3	-1.9	-2.6	-2.4	-1.2	-0.5
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes		Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Aspira Pathlab competitor comparison and performance snapshot within industry

Aspira Pathlab annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Aspira Pathlab Mar-2026 Annual Revenue is Rs 25 Cr which is growth of 13.9% YoY.
NEGATIVE
Annual Net Profit Aspira Pathlab Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of -97.5% YoY.

Aspira Pathlab & Diagnostics Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	19.9%	10.6%	26.4	25.5	22.4	13.6	14.8	19.6	15.4	8.7	7.9	4.6	1.1	0.3
TotalOperatingRevenues_A Operating Rev. Ann.	19.9%	10.5%	25.9	25	22	13.2	14.5	19.5	15.2	8.4	7.6	4.4	0.8
OI_A Other Income Ann.	18.6%	20.1%	0.5	0.5	0.4	0.4	0.3	0.1	0.2	0.3	0.3	0.2	0.3	0.3
OEXPNS_A Operating Exp. Ann.	22.1%	15%	24.9	23.5	18.5	14.4	12.9	13.2	11.7	10.2	10.9	8.2	3.3	0.2
OEXPNS_A Operating Exp. Ann.	22.1%	15%	24.9	23.5	18.5	14.4	12.9	13.2	11.7	10.2	10.9	8.2	3.3	0.2
OP_A Operating Profit Ann.	-2.1%	-15.6%	1	1.5	3.5	-1.2	1.6	6.4	3.5	-1.8	-3.3	-3.9	-2.6	-0.2
OPMPCT_A OPM Ann. %	-18.9%	-24.1%		5.74%	15.74%	-8.71%	10.78%	32.46%	22.80%	-21.00%	-41.15%	-84.60%	-241.35%	-72.39%
TotalExpenses_A Total Exp. Ann. ⌄	19.6%	12.7%		25.5	20.3	16.3	14.9	15.2	14	12.9	13.1	10.2	3.8	0.3
OtherExpenses_A Other Exp. Ann.	27.4%	24.3%	11	8.9	6.5	4.8	4.3	3.8	3	3.3	4.2	3.5	1.6	0.2
EmployeeBenefitExpenses_A Employee Exp. Ann.	16.3%	17.1%	9.4	8.8	7.3	6.2	5.6	5	4	5	4.5	3.4	1.6	0.1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	1.7%	-11.6%		2	3.9	-0.8	1.9	6.5	3.7	-1.5	-3	-3.7	-2.3	0.1
EBIDTPCT_A EBITDA Ann. margin %	-15.7%	-20.3%		7.76%	17.48%	-5.62%	12.95%	32.94%	24.12%	-17.69%	-37.94%	-79.79%	-212.44%	27.61%
INT_A Interest Ann.	0%	-15%	0.4	0.4	0.4	0.4	0.4	0.4	0.9	1	1	0.8	0.3	0.1
DEP_A Depr.	-2.1%	1.4%	1.6	1.5	1.5	1.5	1.6	1.6	1.4	1.7	1.2	1.1	0.2
PBT_A PBT Ann.	-	-41%	-0.5	0.1	2.1	-2.7	-0.1	4.5	1.4	-4.2	-5.2	-5.6	-2.7	0
TAX_A Tax Ann.	-	-								0				0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-41%		0.1	2.1	-2.7	-0.1	4.5	1.4	-4.2	-5.2	-5.6	-2.7	0
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-41%	-0.5	0.1	2.1	-2.7	-0.1	4.5	1.4	-4.2	-5.2	-5.6	-2.7	0
NETPCT_A NPM Ann. %	-	-53.4%		0.20%	9.42%	-20.23%	-0.61%	22.81%	9.08%	-50.38%	-67.86%	-128.10%	-359.08%
EPS_adj_A EPS Adj. latest Ann.	-	-40.1%		0.1	2	-2.6	-0.1	4.3	1.3	-4.1	-5	-5.4	-2.7	0
result_notes Result Notes				Notes			Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

13.8%

2Y CAGR

36.9%

3Y CAGR

19.9%

5Y CAGR

10.6%

7Y CAGR

18.2%

10Y CAGR

55.9%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-95.2%

5Y CAGR

-41%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

27%

2Y CAGR

27.7%

3Y CAGR

22.1%

5Y CAGR

15%

7Y CAGR

11.6%

10Y CAGR

61.1%

Operating Expenses Annual Cr growth is higher than historical averages.

Aspira Pathlab balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Aspira Pathlab Mar-2026 Total Shareholders Fund is Rs 9 Cr which is growth of 1.9% YoY.
POSITIVE
Total Assets Aspira Pathlab Mar-2026 Total Assets is Rs 19 Cr which is growth of 5.7% YoY.

Aspira Pathlab & Diagnostics Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	3.7%	20.7%	8.7	8.5	6.3	7.8	7.9	3.4	3.8	5.2	0.3	5.9	3.6
EQCAP_A Equity Share Capital Ann.	0%	0%	10.3	10.3	10.3	10.3	10.3	10.3	9.3	8.2	5.2	5.2	2.3
TotalShareCapital_A Total Share Capital Ann.	4%	2.4%	11.6	11.5	11.4	10.3	10.3	10.3	9.3	8.2	5.2	5.2	2.3
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-	-	-3	-3	-5.1	-2.5	-2.4	-6.9	-5.5	-3	-4.9	0.7	1.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-	-	-3	-3	-5.1	-2.5	-2.4	-6.9	-5.5	-3	-4.9	0.7	1.4
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-15.7%	3.7%	1.8	1.7	1.4	3	3.6	1.5	5.4	5.4	10.6	3.2
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-11%	19.1%	1.2	1.2	1	1.7	2.4	0.5	0.6	0.5
CL_A Total Current Liabilities Ann. ⌄	24.7%	9.2%	3.1	2.4	2.1	1.6	1.8	2	5.1	4.2	1.6	5.8	2.7
TradePayables_A Trade Payables Ann.	54.2%	9.5%	1.1	0.7	0.7	0.3	0.6	0.7	0.4	0.3	0.2	0.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	16.6%	16.1%	1.9	1.6	1.3	1.2	1.2	0.9	2.4	2	1.3	1.8	0
ShortTermProvisions_A ST Provisions Ann.	-	-	0.1	0.1	0	0	0					0	0
TL_A Total Capital Plus Liabilities Ann.	2.3%	9.4%	18.5	17.5	14.7	17.3	18.1	11.8	14.3	14.8	12.5	14.9	6.3
FixedAssets_A Fixed Assets Ann. ⌄	-3.5%	-1.6%	7.2	6.5	6.8	8	9.6	7.8	8.7	8.9	7.9	8	0
TangibleAssets_A Tangible Assets Ann.	-9.7%	-4.8%	3.9	3.9	4.1	5.3	6.8	5	6	6.2	6.9	6.7	0
IntangibleAssets_A Intangible Assets Ann.	6.9%	3.3%	3.3	2.7	2.7	2.7	2.8	2.8	2.7	2.7	1.1	1.1
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-										0.3
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	6.5%	12%	13.9	12.2	10.4	11.5	11	7.9	11.1	12.5	10.7	10.9	0.6
NonCurrentInvestments_A Non Current Investments Ann.	-	-		0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	5.1%	-	3.6	3.4	3.2	3.1	1.1		0.1	0.4	0.6	0.6	0.5
OtherNonCurrentAssets_A Other Non Current Assets Ann.	97.9%	98.7%	3.1	2.1	0.4	0.4	0.3	0.1	2.3	3.3	2.3	2.3
CA_A Total Current Assets Ann. ⌄	-8%	3.4%	4.6	5.4	4.4	5.9	7.1	3.9	3.3	2.3	1.8	4	5.7
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	-9.6%	0%	1.7	2.4	2.2	2.3	4.5	1.7	0.6	0.8	0.4	0.1	0.1
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-10.9%	7.2%	1.7	2.1	1.4	2.4	1.6	1.2	1.1	0.1	0.2	2.8	5.3
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-										0.5	0.1
OtherCurrentAssets_A Other Current Assets Ann.	-14.5%	-3.6%	0.5	0.4	0.3	0.8	0.6	0.6	1.3	1.1	0.8	0.5	0.2
TA_A Total Assets Ann.	2.3%	9.4%	18.5	17.5	14.7	17.3	18.1	11.8	14.3	14.8	12.5	14.9	6.3
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	1.1	1.1	1.1							0.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

5.7%

2Y CAGR

12.2%

3Y CAGR

2.3%

5Y CAGR

9.4%

7Y CAGR

3.2%

10Y CAGR

11.4%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

29.2%

2Y CAGR

21.5%

3Y CAGR

24.7%

5Y CAGR

9.2%

7Y CAGR

-4.2%

10Y CAGR

1.4%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

2.4%

2Y CAGR

17.5%

3Y CAGR

3.7%

5Y CAGR

20.7%

7Y CAGR

7.6%

10Y CAGR

9.2%

Total ShareHolders Funds Annual growth is lower than historical averages.

Aspira Pathlab ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Aspira Pathlab Mar-2026 Book Value Per Share is 7 Rs which is growth of 0.2% YoY.
POSITIVE
ROE Aspira Pathlab Mar-2026 ROE is 1% which is growth of 27.7% YoY.

Aspira Pathlab & Diagnostics Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	-2.2%	16.6%	7.1	7.1	5.1	7.6	7.6	3.3	4.1	6.3	0.6	11.4	16.2
ROA_A RoA Ann. %	-	-53%	0.27%	11.83%	-18.16%	-0.51%	24.58%	11.72%	-29.58%	-35.02%	-44.54%	-18.33%	0.43%
ROE_A ROE Ann. %	-	-55.7%	0.70%	28.44%	-51.25%	-1.13%	56.73%	40.80%	-111.56%	-99.83%	-1,667.23%	-46.05%	0.75%
ROCE_A ROCE Ann. %	11.2%	-34.2%	2.86%	15.98%	-18.23%	2.08%	29.56%	23.27%	-34.73%	-39.86%	-43.84%	-27.09%	2.41%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-15.7%	-20.2%	7.92%	17.79%	-5.79%	13.24%	33.09%	24.44%	-18.29%	-39.20%	-83.82%	-298.85%
PBITMargin_A EBIT Ann. Margin %	-8.1%	-34.8%	1.76%	11.00%	-17.45%	2.27%	24.72%	14.94%	-38.02%	-55.28%	-109.63%	-325.14%
PBTMargin_A PBT Ann. Margin %	-	-53.4%	0.20%	9.42%	-20.23%	-0.61%	22.81%	9.08%	-50.04%	-67.86%	-128.10%	-359.11%
NETPCT_A NPM Ann. %	-	-53.4%	0.20%	9.42%	-20.23%	-0.61%	22.81%	9.08%	-50.38%	-67.86%	-128.10%	-359.08%
ASETTO_A Asset Turnover Ann. %	20.5%	3.1%	1.4	1.4	0.8	0.8	1.3	1.2	0.6	0.6	0.3	0.1	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-26%	-4.6%	1.5	2.3	2.1	3.7	4	1.9	0.6	0.6	1.1	0.7	2.2
QuickRatio_A Quick Ratio Ann.	-27.4%	-6.3%	1.3	2.1	1.9	3.4	3.8	1.8	0.6	0.5	0.9	0.7	2.2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	28%	14.2%	57.2	86.8	31.6	27.3	65.9	29.4	41.4	29.1	19.2
EVPerNetSales_A EV Per Net Sales Ann.	6.6%	3.9%	2.3	4	2.4	1.9	3.4	1.9	4.9	3.8	4.4	-
PBV_A Price To Book Value Adjusted	-13.8%	-22.7%	10.94	10.95	25.67	17.11	17.03	39.54	31.79	20.52	201.89	11.41	8.04
EVPerEBITDA_A EV Per EBITDA Ann.	26.4%	29.6%	28.9	22.2	-41.3	14.3	10.2	7.9	-26.9	-9.7	-5.3	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	4.8%	3.9%	2.3	4	2.4	2	3.4	1.9	4.2	2.9	2	-
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	-	-		0	-0.1		0.1	0.1	-0.1	-0.2	-0.6
DEBT_CE_A Total Debt to Total Equity Ann.						0.1	0.1	0.4	1.8	1.3	31.6	1.2	0.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-97.5%

5Y CAGR

-55.7%

10Y CAGR

-0.7%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-97.7%

5Y CAGR

-53%

10Y CAGR

-4.5%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-34.8%

2Y CAGR

-15.5%

3Y CAGR

-26%

5Y CAGR

-4.6%

7Y CAGR

14%

10Y CAGR

-3.8%

Current Ratio Annual is falling faster than historical averages.

Aspira Pathlab cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Aspira Pathlab Mar-2026 Cash From Operating Activity is Rs 1 Cr which is growth of -22.6% YoY.
NEGATIVE
Net Cash Flow Aspira Pathlab Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -151.4% YoY.

Aspira Pathlab & Diagnostics Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-	-23.4%	1.5	1.9	1.1	-0	2	5.7	-1.9	-3.4	-4.8	-1.3	-0.4
PBT_A PBT Ann.	-	-41%	0.1	2.1	-2.7	-0.1	4.5	1.4	-4.2	-5.2	-5.6	-2.7	0
INT_A Interest Ann.	0%	-15%	0.4	0.4	0.4	0.4	0.4	0.9	1	1	0.8	0.3	0.1
TAX_A Tax Ann.	-	-							0				0
CFI_A Cash from Investing Act. Ann.	-	-	-0.8	0.1	0.1	0.2	-0.5	-0.1	0.2	-2	-0.8	-10.1	-0
CFA_A Cash from Financing Act. Ann.	-	-	-1.1	-1	-1	-0.9	-1.4	-2.2	1.3	3.4	6.5	8.9	2.6
NCF_A Net Cash Flow Ann. ⌄	-	-	-0.5	1	0.2	-0.8	0.2	3.4	-0.4	-2	0.9	-2.5	2.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	8.7%	-	1.8	0.8	0.6	1.4	1.2	-2.2	-1.9	0.1	-0.8	5.3	3.1
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	29.4%	1.6%	1.3	1.8	0.8	0.6	1.4	1.2	-2.2	-1.9	0.1	2.8	5.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-21.1%

2Y CAGR

16.8%

5Y CAGR

-23.4%

Cash from Operating Activity Annual is falling faster than historical averages.

Aspira Pathlab investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

New 52W High in past week

High vol.+gain this week

Aspira Pathlab quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents